Sajid Qureshi
Overview
Explore the profile of Sajid Qureshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdelhafeez A, Reljic T, Klocksieben F, Kumar A, Cox S, Davidoff A, et al.
Pediatr Blood Cancer
. 2025 Jan;
72(4):e31541.
PMID: 39870584
Background: Surgery remains the cornerstone of treatment for rhabdomyosarcoma (RMS) in children. However, there is considerable variation in surgical management practices worldwide, highlighting the need for standardized Clinical Practice Guidelines...
2.
Niharika V, Patkar S, Pai T, Qureshi S
Indian J Pediatr
. 2025 Jan;
PMID: 39794671
Less than 20 cases of primary hepatic rhabdomyosarcoma have been reported in literature. The authors present this occurrence in a neonate with paravertebral and peritoneal disease. Histopathology was the solution...
3.
Parambil B, Khemani P, Puri A, Gulia A, Prasad M, Gollamudi V, et al.
Pediatr Blood Cancer
. 2024 Dec;
72(3):e31471.
PMID: 39676122
Background: Histopathological response to neoadjuvant chemotherapy (NACT) measured as tumor necrosis (TN) has been reported to be prognostic post-high-dose methotrexate (HDMTX)-based chemotherapy. We studied this on a non-HDMTX chemotherapy backbone....
4.
Pio L, Loh A, Harrison D, Gonzalez G, Qureshi S, Lakhoo K, et al.
Pediatr Blood Cancer
. 2024 Aug;
:e31238.
PMID: 39099136
This report summarizes the status of pediatric surgical oncology services in low- and middle-income countries. Factors such as surgical capacity and enablers, and barriers to providing pediatric surgical oncology services...
5.
Ramanathan S, Sisodiya S, Shetty O, Prasad M, C Parambil B, Shah S, et al.
Ecancermedicalscience
. 2023 May;
17:1539.
PMID: 37138963
While factors influencing outcomes of rhabdomyosarcoma (RMS) in developed countries have evolved from clinical characteristics to molecular profiles, similar data from developing countries are scarce. This is a single-centre analysis...
6.
Srinivasan S, Prasad M, C Parambil B, Shrimal A, Gollamudi V, Subramani V, et al.
Pediatr Blood Cancer
. 2023 Apr;
70(7):e30302.
PMID: 37046413
Background: Not all the significant progress made in the management of children with hepatoblastoma (HB) has translated into improved outcomes in limited-resource settings. There are limited data on outcomes in...
7.
Yadav S, Mittal N, Bal M, Qureshi S
J Maxillofac Oral Surg
. 2023 Mar;
21(4):1343-1347.
PMID: 36896065
Cemento-ossifying fibromas are benign fibro-osseous lesions characterized by deposition of cementum and fibrous tissue. Familial gigantiform cementoma (FGC) is an exceeding rare and distinct subtype of cemento-osseous-fibrous lesion. We hereby...
8.
Ramanathan S, Prasad M, Vora T, Badira C, Kembhavi S, Ramadwar M, et al.
Pediatr Blood Cancer
. 2023 Jan;
70(4):e30179.
PMID: 36645132
Background And Aims: Data on the outcome and prognostic indicators in extracranial relapsed/refractory germ cell tumors (rel/ref-GCTs) in children are limited to a few studies. This study looks at remission...
9.
Parambil B, Shah S, Prasad M, Vora T, Laskar S, Khanna N, et al.
J Pediatr Hematol Oncol
. 2022 Oct;
45(3):e363-e369.
PMID: 36251857
Background: Persisting residual masses at treatment completion are known in rhabdomyosarcoma (RMS) treated with definitive radiotherapy (RT) to the primary site, but their prognostic significance is uncertain. Tumor response as...
10.
Ramanathan S, Prasad M, Vora T, C Parambil B, Kembhavi S, Ramadwar M, et al.
Pediatr Blood Cancer
. 2022 May;
69(7):e29765.
PMID: 35561025
Background: The purpose of this single-center study was to analyze the outcomes of extracranial germ cell tumors (GCTs) in children treated on a multimodality regimen. Methods: Retrospective study of children...